Boehringer Avoids Further Efficacy Study Of Ofev In SSc-ILD With Full Approval, No Post-Marketing Commitments

 
• By Michael Cipriano
  
Neon Light Sign Lungs Icon
The FDA approved Ofev for SSc-ILD, a rare lung disease.

More from Approvals

More from Product Reviews